iShares Biotechnology ETF $IBB Holdings Decreased by Bristlecone Advisors LLC

Bristlecone Advisors LLC reduced its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 14.8% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 786 shares of the financial services provider’s stock after selling 137 shares during the quarter. Bristlecone Advisors LLC’s holdings in iShares Biotechnology ETF were worth $99,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Signet Financial Management LLC grew its stake in iShares Biotechnology ETF by 3.3% during the 2nd quarter. Signet Financial Management LLC now owns 2,579 shares of the financial services provider’s stock worth $326,000 after buying an additional 83 shares during the last quarter. Optimum Investment Advisors grew its stake in iShares Biotechnology ETF by 2.6% during the 2nd quarter. Optimum Investment Advisors now owns 3,345 shares of the financial services provider’s stock worth $423,000 after buying an additional 84 shares during the last quarter. Apollon Wealth Management LLC grew its stake in iShares Biotechnology ETF by 1.1% during the 1st quarter. Apollon Wealth Management LLC now owns 8,754 shares of the financial services provider’s stock worth $1,120,000 after buying an additional 96 shares during the last quarter. SBI Securities Co. Ltd. grew its stake in iShares Biotechnology ETF by 5.2% during the 1st quarter. SBI Securities Co. Ltd. now owns 2,198 shares of the financial services provider’s stock worth $281,000 after buying an additional 108 shares during the last quarter. Finally, KFG Wealth Management LLC grew its stake in iShares Biotechnology ETF by 4.8% during the 2nd quarter. KFG Wealth Management LLC now owns 2,444 shares of the financial services provider’s stock worth $309,000 after buying an additional 112 shares during the last quarter. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Stock Performance

Shares of IBB opened at $156.97 on Thursday. The stock has a fifty day moving average price of $146.02 and a 200 day moving average price of $133.75. iShares Biotechnology ETF has a 12 month low of $107.43 and a 12 month high of $158.64.

iShares Biotechnology ETF Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, September 19th. Investors of record on Tuesday, September 16th were paid a dividend of $0.0828 per share. This represents a $0.33 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date was Tuesday, September 16th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.